Membrane Flux Not Biocompatibility Determines Beta-2-Microglobulin Levels in Hemodialysis Patients
T Pickett(Gloucestershire Royal Hospital), Ken Farrington(University of Hertfordshire), Roger Greenwood(Mount Sinai Beth Israel), A Cruickshank(Lister Hospital), Andrew Davenport(The Royal Free Hospital), David Taube(Hammersmith Hospital)
Cited by 23
Related Papers
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative
|European Heart Journal|2009|1.1k
Vascular access use in Europe and the United States: Results from the DOPPS
|Kidney International|2002|855
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
|Kidney International|2020|724
Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)
|Nephrology Dialysis Transplantation|2003|472